← Evidence map

ArticleCancer immunology, immunotherapy : CII2006

Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer.

Sung-Hyung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 16565828